$0.46
-0.01 (-1.19%)
Open$0.46
Previous Close$0.46
Day High$0.46
Day Low$0.43
52W High$2.01
52W Low$0.39
Volume—
Avg Volume118.9K
Market Cap5.25M
P/E Ratio—
EPS$-1.06
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 188.5K | 181.4K | 1.91M |
| Net Income | -7,541,655 | -6,530,827 | 328.9K |
| Profit Margin | -4,011.7% | -3,811.2% | 17.2% |
| EBITDA | -4,282,280 | -3,914,332 | 495.2K |
| Free Cash Flow | — | — | 411.8K |
| Rev Growth | +3.9% | +3.9% | -9.8% |
| Debt/Equity | 0.27 | 0.27 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |